Company Description
Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States.
The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds, including equine care.
Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services.
It also offers surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services.
The company was incorporated in 2020 and is based in Virginia Beach, Virginia.
Country | United States |
Founded | 2020 |
IPO Date | Aug 30, 2023 |
Industry | Personal Services |
Sector | Consumer Discretionary |
Employees | 156 |
CEO | Kimball Carr |
Contact Details
Address: 780 Lynnhaven Pkwy #400 Virginia Beach, Virginia 23452 United States | |
Phone | (757) 288-3088 |
Website | inspirevet.com |
Stock Details
Ticker Symbol | IVP |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $4.00 |
CIK Code | 0001939365 |
CUSIP Number | 45784E106 |
ISIN Number | US45784E1064 |
Employer ID | 85-4359258 |
SIC Code | 0700 |
Key Executives
Name | Position |
---|---|
Kimball Carr | Chairman, Chief Executive Officer and President |
Richard Paul Frank | Chief Financial Officer |
Dr. Alexandra Quatri | Vice President of Medical Operations |
Lynley Kees | Vice President of Human Resources |
Zander Carraway | Director of Acquisitions |
Richard S. Marten Esq. | Secretary |
Debbe Bastian | Finance Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 19, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Jul 15, 2024 | 8-K | Current Report |
Jul 9, 2024 | 424B4 | Prospectus |
Jul 2, 2024 | EFFECT | Notice of Effectiveness |
Jul 1, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jun 26, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jun 24, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jun 14, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Jun 10, 2024 | 8-K | Current Report |
May 28, 2024 | DEF 14C | Filing |